Register entry

Biofrontera Bioscience GmbH

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
3
Exclusivities
1
Countries
1
Base
Germany
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Biofrontera Pharma GmbHRegistrant: Biofrontera Bioscience GmbHHemmelrather Weg 201, Leverkusen, North Rhine-Westphalia 51377, Germany (DEU)Analytical testing3011764519332358501
Exclusivity

Patents and exclusivities

3
PatentProductCoversExpiry
11540981AMELUZaminolevulinic acid hydrochlorideproductFeb 2028
11235169AMELUZaminolevulinic acid hydrochlorideuseOct 2040
12280146AMELUZaminolevulinic acid hydrochlorideproductDec 2043
ProductExclusivityUntil
AMELUZAMINOLEVULINIC ACID HYDROCHLORIDED-194 New dosing scheduleOct 2027
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
AMELUZaminolevulinic acid hydrochloridegel, topical70621-101NDA
Neighbours

Registered in the same town

4
Compare

Comparable companies in Germany

Enquiry

Common questions

Is Biofrontera Bioscience GmbH FDA approved?
Biofrontera Bioscience GmbH holds 1 FDA-registered establishment in Germany. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Biofrontera Bioscience GmbH's registered sites?
The FDA register lists Leverkusen. Registered operations: analytical testing.
What drugs does Biofrontera Bioscience GmbH make?
1 product is listed under Biofrontera Bioscience GmbH in the openFDA NDC Directory, most often as gel. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.